-
Swimming N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-23 Margaret Isaac
Two decades ago, unable to swim, a palliative care physician was saved from a muscular riptide by a lifeguard. The sensation of drowning comes back to haunt her during the catastrophic time of the pandemic.
-
Herpes Simplex Dendritic Keratitis N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-23 Giuseppe Giannaccare, Massimiliano Borselli
-
A Holy Grail — The Prediction of Protein Structure N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-21 Russ B. Altman
The 2023 Lasker Award for Basic Medical Research underscores the value of an AI system that predicts the three-dimensional structure of proteins from the one-dimensional sequence of their amino acids.
-
Optical Coherence Tomography and Eye Care N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-21 Cynthia A. Toth
The 2023 Lasker–DeBakey Clinical Medical Research Award recognizes the effect of optical coherence tomography, invented by Drs. Fujimoto, Huang, and Swanson.
-
From Ashes to Action — Indigenous Health Perspectives on the Lāhainā Fires N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-20 Kekoa Taparra, Mālia Purdy, Kalani L. Raphael
Historical oppression fueled both the Lāhainā fires and the health inequities faced by Native Hawaiian communities. Healing and rebuilding should be shaped by community voices and perspectives.
-
Skin Cancer after Ruxolitinib or Belumosudil N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-21
To the Editor: Lee and colleagues (July 13 issue)1 describe two patients with chronic graft-versus-host-disease (GVHD) in whom aggressive cutaneous squamous-cell carcinoma developed while they received treatment that included ruxolitinib or belumosudil, recently approved drugs for the management of chronic GVHD. These two patients had multiple risk factors for cutaneous squamous-cell carcinoma, including
-
Armed-Assailant Drills in U.S. Schools N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-21
To the Editor: Although the Perspective article by Miotto and Cogan (July 6 issue)1 calls attention to an important issue, it contains some factually incorrect statements. Existing research refutes claims that there are no data to inform us about how often drills should be conducted or their effects on actual school shootings.2 The authors reported that we performed unscheduled surprise active-shooter
-
Axicabtagene Ciloleucel in Large B-Cell Lymphoma N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-21
To the Editor: The ZUMA-7 trial showed breakthrough progress in the treatment of early relapsed or refractory large B-cell lymphoma. However, Westin et al. (July 13 issue)1 listed limitations such as the low proportion of non-Hispanic patients, restricted eligibility as compared with the real-world distribution of the disease, and the absence of patients who were ineligible for autologous stem-cell
-
Variant STAT4 and Treatment of an Autoinflammatory Syndrome N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-21
To the Editor: We describe the case of a 21-year-old man who died from an intractable disabling pansclerotic morphea (DPM). The disease began when he was 12 years of age and manifested as localized morphea with multiple oval, shiny, and thickened lesions. At 16 years of age, severe erosive ulcers developed on his hands, feet, and legs, resulting in a highly disabling form of DPM (
-
Cardiovascular Safety of Testosterone-Replacement Therapy N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-21
To the Editor: Lincoff et al. (July 13 issue)1 report the results of the Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Efficacy Response in Hypogonadal Men (TRAVERSE) trial, a noninferiority trial comparing the effect of testosterone-replacement therapy with that of placebo on major adverse cardiac events in men with hypogonadism and preexisting or high cardiovascular
-
Case 29-2023: A 34-Year-Old Woman with Abdominal Distention and Acute Kidney Injury N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-21 Sundar Jagannath, Mark A. Anderson, Andrew J. Yee, Robert P. Hasserjian
A 34-year-old woman was admitted to the hospital because of abdominal distention, fatigue, and acute kidney injury that occurred 10 months after orthotopic liver transplantation. A diagnosis was made.
-
Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-21 Eric Bouffet, Jordan R. Hansford, Maria Luisa Garrè, Junichi Hara, Ashley Plant-Fox, Isabelle Aerts, Franco Locatelli, Jasper van der Lugt, Ludmila Papusha, Felix Sahm, Uri Tabori, Kenneth J. Cohen, Roger J. Packer, Olaf Witt, Larissa Sandalic, Ana Bento Pereira da Silva, Mark Russo, Darren R. Hargrave
Background Detection of the BRAF V600E mutation in pediatric low-grade glioma has been associated with a lower response to standard chemotherapy. In previous trials, dabrafenib (both as monotherapy and in combination with trametinib) has shown efficacy in recurrent pediatric low-grade glioma with BRAF V600 mutations, findings that warrant further evaluation of this combination as first-line therapy
-
Type 2 Diabetes — Controlling the Epidemic, Episode 2: After the Diagnosis — Making a Plan and Addressing Social Determinants of Health N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-21 E. Dale Abel, Julie R. Ingelfinger, Joshua Kolko, Suyanna Linhales Barker, Dinora Lopez, Mirna Mejia, Monica Peek, Jane E.B. Reusch, Clifford J. Rosen
In this second episode of “Type 2 Diabetes — Controlling the Epidemic,” a four-part Double Take video miniseries from the New England Journal of Medicine, Drs. Jane E.B. Reusch (University of Colorado), E. Dale Abel (UCLA), and Monica Peek (University of Chicago) describe the process of tailoring type 2 diabetes interventions and education to the individual patient. The video also highlights the impact
-
Reducing the Risks of Nuclear War — The Role of Health Professionals N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-16 Kamran Abbasi, Parveen Ali, Virginia Barbour, Kirsten Bibbins-Domingo, Marcel GM Olde Rikkert, Andy Haines, Ira Helfand, Richard Horton, Bob Mash, Arun Mitra, Carlos Monteiro, Elena N. Naumova, Eric J. Rubin, Tilman Ruff, Peush Sahni, James Tumwine, Paul Yonga, Chris Zielinski
In January 2023, the Science and Security Board of the Bulletin of the Atomic Scientists moved the hands of the Doomsday Clock forward to 90 seconds before midnight, reflecting the growing risk of nuclear war.1 In August 2022, United Nations Secretary-General António Guterres warned that the world is now in “a time of nuclear danger not seen since the height of the Cold War.”2 The danger has been underlined
-
The New USPSTF Mammography Recommendations — A Dissenting View N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-16 Steven Woloshin, Karsten Juhl Jørgensen, Shelley Hwang, H. Gilbert Welch
The evidence for breast cancer screening of women in their 40s is insufficient to support a new public health imperative, given the uncertain benefits and common harms for healthy women.
-
The Ethics of Abortion Care Advocacy — Making Exceptions to the Rule N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-16 Beverly Gray, Jonas J. Swartz
Requests to help mold abortion legislation that runs counter to evidence-based medicine create substantial moral distress for clinicians and raise important ethical questions about how to respond.
-
Hydrofluorocarbons, Climate, and Health N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-14
To the Editor: In his Perspective article, Woodcock (June 29 issue)1 appropriately praises the effectiveness of the Montreal Protocol and argues for increased phasedown of hydrofluorocarbons (HFCs). However, there are three points that we think require some corrective clarification. First, the Antarctic ozone hole was not the proof of Rowland and Molina’s laboratory results. Computer models in the
-
Clinical Examination of the Cranial Nerves N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-14
To the Editor: As shown in the Videos in Clinical Medicine by Singh et al.,1 visual-field testing by confrontation is an important bedside examination technique in screening for defects in the anterior (retina and optic nerve) and posterior (optic chiasm to occipital lobe) visual pathways. Although confrontation testing has high specificity as compared with automated perimetry, its sensitivity is low
-
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-14
To the Editor: Kampmann et al. (Apr. 20 issue)1 report the results of the Maternal Immunization Study for Safety and Efficacy (MATISSE). Breast-feeding is an important potential modifying factor for respiratory syncytial virus (RSV) infection,2 and indeed the trial protocol says that these data will be collected. Can the authors provide outcomes stratified according to some, all, or no breast-feeding
-
Pegozafermin for NASH — A Sprint to Start a Marathon N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-14 Mary E. Rinella
Pharmacotherapy in patients with nonalcoholic steatohepatitis (NASH) has been a frustrating endeavor, with failures outnumbering successes by some margin, even in late-phase clinical trials. The complex pathobiologic features of NASH, the slow and variable natural history of the disease, and the nefarious nature of assessing histologic end points have contributed to the difficulty of attaining efficacy
-
Case 28-2023: A 37-Year-Old Man with a Rash N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-14 Frank M. Volpicelli, Robert H. Goldstein, E. Zachary Nussbaum
A 37-year-old man was admitted because of difficulty with swallowing and a diffuse maculopapular rash. Laboratory evaluation revealed lymphopenia and an elevated globulin gap. A diagnosis was made.
-
Paradoxical Abdominal Movement N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-14 Vishal Mangal, Anil S. Menon
-
Antibiotic Prophylaxis in Infants with Grade III, IV, or V Vesicoureteral Reflux N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-14 William Morello, Esra Baskin, Augustina Jankauskiene, Fatos Yalcinkaya, Aleksandra Zurowska, Giuseppe Puccio, Jessica Serafinelli, Angela La Manna, Grażyna Krzemień, Marco Pennesi, Claudio La Scola, Francesca Becherucci, Milena Brugnara, Selcuk Yuksel, Djalila Mekahli, Roberto Chimenz, Diego De Palma, Pietro Zucchetta, Donatas Vajauskas, Dorota Drozdz, Maria Szczepanska, Salim Caliskan, Jacques Lombet
Background The efficacy of continuous antibiotic prophylaxis in preventing urinary tract infection (UTI) in infants with grade III, IV, or V vesicoureteral reflux is controversial. Methods Download a PDF of the Research Summary. In this investigator-initiated, randomized, open-label trial performed in 39 European centers, we randomly assigned infants 1 to 5 months of age with grade III, IV, or V vesicoureteral
-
Selective Antimicrobial Prophylaxis for Vesicoureteral Reflux N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-14 Tej K. Mattoo
The use of continuous antibiotic prophylaxis in the prevention of urinary tract infection (UTI), particularly in children with vesicoureteral reflux, has been studied extensively during the past 15 years. Double-blind, placebo-controlled trials such as the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) trial and the Prevention of Recurrent Urinary Tract Infection in Children
-
Threatening the Global AIDS Response — Obstacles to PEPFAR’s Reauthorization N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-09 Salim S. Abdool Karim, Francoise Barre-Sinoussi, Harold E. Varmus, David Serwadda, Elizabeth Bukusi, Souleymane M’boup, Adeeba Kamarulzaman, Soumya Swaminathan, Jean W. Pape
Some members of the U.S. Congress want to apply the “global gag rule” regarding abortion to the President’s Emergency Plan for AIDS Relief, jeopardizing this essential global AIDS control program.
-
A Doctrine in Name Only — Strengthening Prohibitions against the Corporate Practice of Medicine N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-09 Jane M. Zhu, Hayden Rooke-Ley, Erin Fuse Brown
Rapid corporatization of health care raises questions about the corporate-practice-of-medicine doctrine and whether state laws could be strengthened to protect the profession and the public interest.
-
The Accelerated Approval Program for Cancer Drugs — Finding the Right Balance N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-09 Bishal Gyawali, Aaron S. Kesselheim, Joseph S. Ross
Recently, the FDA proposed guidance that would update the accelerated approval pathway for cancer drugs. Although the guidance includes important provisions, it could be strengthened.
-
A Shared Mission N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-09 Howard Holtz
Though health care consolidation was supposed to improve care coordination, a primary care physician in private practice finds specialists increasingly unlikely to keep him informed about patients.
-
Sleeve Sign and Inverse Gottron’s Papules in Anti-MDA5 Dermatomyositis N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-09 Wei-Yao Wang, Shih-Tsung Cheng
-
Affirmative Action, Population Health, and the Importance of Opportunity and Hope N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-06 Atheendar S. Venkataramani
Policy discussions related to affirmative action have typically focused on its effects on education, employment, and earnings. But affirmative action may also play a role in shaping population health.
-
More on Autochthonous Leprosy in the United States N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-07
To the Editor: In a recent letter to the editor, Belzer et al. (June 29 issue)1 note that armadillos as a maintenance host cannot account for all current cases of autochthonous leprosy in the United States. Armadillos also die from the disease, and whether the pathogen is maintained permanently in wild populations of armadillos is undetermined. In addition to armadillos, other animal hosts have been
-
Idiopathic Pulmonary Hemosiderosis N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-07
To the Editor: Uda and Yashiro (June 8 issue)1 report a case that they described as idiopathic pulmonary hemosiderosis. Although the imaging provides an illustrative example for which alveolar hemorrhage is an important etiologic consideration, we wish to highlight additional critical steps in the evaluation of children with these imaging findings — namely, lung biopsy and genetic testing. Idiopathic
-
Semaglutide in Early Type 1 Diabetes N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-07 Paresh Dandona, Ajay Chaudhuri, Husam Ghanim
In this small case series, semaglutide after the diagnosis of type 1 diabetes led to elimination of prandial insulin in all patients and basal insulin in most, along with improved glycemic control.
-
Engineering CAR T Cells for Off-the-Shelf Use N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-07 Dan L. Longo
This editorial describes the science behind a study that used base-edited CAR T cells to treat patients with T-cell lymphoblastic leukemia.
-
Next Chapter for Weight Control — Small-Molecule GLP-1 Receptor Agonists? N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-07 E. Dale Abel
Obesity is a major risk factor for many health conditions, including cardiovascular disease, type 2 diabetes, sleep apnea, and cancer. The therapeutic armamentarium for long-term weight management is limited by side effects and contraindications.1 Two injectable incretin-based glucagon-like peptide-1 (GLP-1) receptor agonists — liraglutide (3.0 mg daily) and semaglutide (2.4 mg weekly) — have been
-
It’s All in the Timing N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-07 Alexander J. Beagle, Bernie Y. Sunwoo, Rebecca L. Olin, Brian S. Schwartz, Brian L. Block
A 55-year-old man with acute myeloid leukemia began to have shortness of breath, cough with blood-tinged sputum, and hypoxemia 17 days after receiving a myeloablative allogeneic stem-cell transplant from a haploidentical donor.
-
Current and Emerging Issues in Wilson’s Disease N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-07 Eve A. Roberts, Michael L. Schilsky
Wilson’s disease, which may lead to severe copper overload and multiorgan dysfunction, is best managed collaboratively by specialists in hepatology, neurology, psychiatry, and clinical genetics.
-
Type 2 Diabetes — Controlling the Epidemic, Episode 1: Understanding and Preventing Type 2 Diabetes N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-07 E. Dale Abel, Jessica Giffin, Julie R. Ingelfinger, Monica Peek, Jane E.B. Reusch, Clifford J. Rosen, Amy Sagendorf, Edwin Thomas
In this first episode of “Type 2 Diabetes — Controlling the Epidemic,” a four-part Double Take video miniseries from the New England Journal of Medicine, Drs. Jane E.B. Reusch (University of Colorado), E. Dale Abel (UCLA), and Monica Peek (University of Chicago) discuss the pathophysiology of the disease and its common complications. The experts also review prediabetes and the importance of engaging
-
Threatening the Future of Global Health — NIH Policy Changes on International Research Collaborations N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-02 Albert I. Ko, Salim S. Abdool Karim, Carlos Morel, Soumya Swaminathan, Peter Daszak, Gerald T. Keusch
A new policy for foreign subrecipients of NIH funding departs sharply from decades of efforts to promote research integrity and build research capacity globally — and may have wide-ranging negative consequences.
-
Mass Masking without Mandates — The Role of Gender in Mask Use in China N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-02 Meng Zhang
In 20th-century China, gender norms were often a factor in the decision to wear a mask during an epidemic, and public health authorities and businesses took advantage of this.
-
Lonomia obliqua Envenomation N. Engl. J. Med. (IF 158.5) Pub Date : 2023-09-02 Nicolas Peruzzo, Gustavo Gössling
-
Preventing Heat-Related Illness among Outdoor Workers — Opportunities for Clinicians and Policymakers N. Engl. J. Med. (IF 158.5) Pub Date : 2023-08-30 Rosemary K. Sokas, Emily Senay
Efforts to implement heat-safety protections for workers are falling short. Given these gaps, clinicians can help support their patients who may be at risk for heat-related illness.
-
Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma N. Engl. J. Med. (IF 158.5) Pub Date : 2023-08-30 Paul G. Richardson, Suzanne Trudel, Rakesh Popat, María-Victoria Mateos, Annette J. Vangsted, Karthik Ramasamy, Joaquín Martinez-Lopez, Hang Quach, Robert Z. Orlowski, Mario Arnao, Sagar Lonial, Chatchada Karanes, Charlotte Pawlyn, Kihyun Kim, Albert Oriol, Jesus G. Berdeja, Paula Rodríguez Otero, Ignacio Casas-Avilés, Alessia Spirli, Jennifer Poon, Shaoyi Li, Jing Gong, Lilly Wong, Manisha Lamba,
Background Despite recent progress, multiple myeloma remains incurable. Mezigdomide is a novel cereblon E3 ubiquitin ligase modulator with potent antiproliferative and tumoricidal activity in preclinical models of multiple myeloma, including those resistant to lenalidomide and pomalidomide. Methods In this phase 1–2 study, we administered oral mezigdomide in combination with dexamethasone to patients
-
Mezigdomide and Multiple Myeloma N. Engl. J. Med. (IF 158.5) Pub Date : 2023-08-30 Jake Shortt
This editorial describes the science behind a study of mezigdomide, which augments the degradation of the proteins Ikaros and Aiolos, to treat multiple myeloma.
-
PD-1 and PD-L1 Blockade plus Chemotherapy in Endometrial Cancer N. Engl. J. Med. (IF 158.5) Pub Date : 2023-08-31
To the Editor: The trials by Mirza et al. and Eskander et al. (June 8 issue)1,2 showed that the addition of immune checkpoint inhibitor therapies to standard chemotherapy significantly improved progression-free survival among women who received a diagnosis of advanced mismatch repair–deficient (dMMR) endometrial cancer. The response rate among patients with advanced mismatch repair–proficient (pMMR)
-
Transcatheter Repair for Patients with Tricuspid Regurgitation N. Engl. J. Med. (IF 158.5) Pub Date : 2023-08-31
To the Editor: An accurate examination of the baseline characteristics of the patients in the Trial to Evaluate Cardiovascular Outcomes in Patients Treated with the Tricuspid Valve Repair System Pivotal (TRILUMINATE Pivotal) by Sorajja et al. (May 18 issue)1 suggests a considerable overlap with heart failure with preserved ejection fraction, an extremely heterogeneous syndrome. The majority of patients
-
Craniectomy or Craniotomy for Acute Subdural Hematoma N. Engl. J. Med. (IF 158.5) Pub Date : 2023-08-31
To the Editor: Hutchinson and colleagues (June 15 issue)1 report that in patients with traumatic acute subdural hematoma, surgical evacuation by means of routine depressive craniectomy (in which the bone flap is not replaced) provides no outcome benefit over craniotomy (in which the bone flap is replaced). We are interested in clarification of some issues to assist in understanding the implications
-
Sucralose and Erythritol — Not Too Sweet N. Engl. J. Med. (IF 158.5) Pub Date : 2023-08-31 Herbert Tilg, Timon E. Adolph
A provisional recommendation from the WHO against the use of artificial sweeteners to control body weight is supported by preclinical studies showing effects on immunity and cardiovascular health.
-
Mind the Gap — Timing of Cleft Palate Repair N. Engl. J. Med. (IF 158.5) Pub Date : 2023-08-31 Raymond Tse, Oksana Jackson
Orofacial clefts are the most common congenital facial anomaly. Fusion of the primary palate at 4 to 6 weeks of gestation facilitates the formation of the lip, nose, alveolus, and anterior hard palate. Fusion of the secondary palate at 6 to 12 weeks of gestation facilitates the formation of the posterior hard palate and the soft palate. The failure of fusion results in a gap that we call a “cleft.”
-
Hemostasis — A Balancing Act N. Engl. J. Med. (IF 158.5) Pub Date : 2023-08-31 H. Marijke van den Berg, Alok Srivastava
This editorial describes the science behind a clinical trial of concizumab, an inhibitor of a naturally occurring anticoagulant, to treat hemophilia A and B.
-
Case 27-2023: A 53-Year-Old Woman with Celiac Disease and Upper Gastrointestinal Bleeding N. Engl. J. Med. (IF 158.5) Pub Date : 2023-08-31 Nikroo Hashemi, Emily W. Lopes, Ranjodh S. Dhami, Angela E. Lin, Jinesa Moodley
A 53-year-old woman with celiac disease was admitted with diarrhea and hemorrhagic shock. Imaging was notable for a retroperitoneal mass and horseshoe kidney. A diagnosis was made.
-
Renal Artery Thrombosis in Essential Thrombocythemia N. Engl. J. Med. (IF 158.5) Pub Date : 2023-08-31 Thibault Laban, Nizar Joher
-
Considering Biased Data as Informative Artifacts in AI-Assisted Health Care N. Engl. J. Med. (IF 158.5) Pub Date : 2023-08-31 Kadija Ferryman, Maxine Mackintosh, Marzyeh Ghassemi
Medical AI tools that are trained on skewed data may exhibit bias. The authors discuss how thinking of clinical data as artifacts can identify values, practices, and patterns of inequity in health care.
-
CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease N. Engl. J. Med. (IF 158.5) Pub Date : 2023-08-31 Akshay Sharma, Jaap-Jan Boelens, Maria Cancio, Jane S. Hankins, Prafulla Bhad, Marjohn Azizy, Andrew Lewandowski, Xiaojun Zhao, Shripad Chitnis, Radhika Peddinti, Yan Zheng, Neena Kapoor, Fabio Ciceri, Timothy Maclachlan, Yi Yang, Yi Liu, Jianping Yuan, Ulrike Naumann, Vionnie W.C. Yu, Susan C. Stevenson, Serena De Vita, James L. LaBelle
Background Sickle cell disease is caused by a defect in the β-globin subunit of adult hemoglobin. Sickle hemoglobin polymerizes under hypoxic conditions, producing deformed red cells that hemolyze and cause vaso-occlusion that results in progressive organ damage and early death. Elevated fetal hemoglobin levels in red cells protect against complications of sickle cell disease. OTQ923, a clustered regularly
-
Anti–Epstein–Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer N. Engl. J. Med. (IF 158.5) Pub Date : 2023-08-31 Tingdong Li, Fugui Li, Xiaoyi Guo, Congming Hong, Xia Yu, Biaohua Wu, Shifeng Lian, Liuwei Song, Jiabao Tang, Shunhua Wen, Kaimin Gao, Mengling Hao, Weimin Cheng, Yingying Su, Shiyin Zhang, Shoujie Huang, Mujin Fang, Yingbin Wang, Mun-Hon Ng, Honglin Chen, Wenxin Luo, Shengxiang Ge, Jun Zhang, Ningshao Xia, Mingfang Ji
Background Population screening of asymptomatic persons with Epstein–Barr virus (EBV) DNA or antibodies has improved the diagnosis of nasopharyngeal carcinoma and survival among affected persons. However, the positive predictive value of current screening strategies is unsatisfactory even in areas where EBV is endemic. Methods We designed a peptide library representing highly ranked B-cell epitopes
-
Timing of Primary Surgery for Cleft Palate N. Engl. J. Med. (IF 158.5) Pub Date : 2023-08-31 Carrol Gamble, Christina Persson, Elisabeth Willadsen, Liz Albery, Helene Soegaard Andersen, Melissa Zattoni Antoneli, Malin Appelqvist, Ragnhild Aukner, Pia Bodling, Melanie Bowden, Karin Brunnegård, Gillian Cairns, Samantha Calladine, Linsay Campbell, Jill Clayton-Smith, Rachael Cooper, Elizabeth Conroy, Ahmed El-Angbawi, Berit Kildegaard Emborg, Josefin Enfält Wikman, Beth Fitzpatrick, Ana Paula
Background Among infants with isolated cleft palate, whether primary surgery at 6 months of age is more beneficial than surgery at 12 months of age with respect to speech outcomes, hearing outcomes, dentofacial development, and safety is unknown. Methods Download a PDF of the Research Summary. We randomly assigned infants with nonsyndromic isolated cleft palate, in a 1:1 ratio, to undergo standardized
-
Phase 3 Trial of Concizumab in Hemophilia with Inhibitors N. Engl. J. Med. (IF 158.5) Pub Date : 2023-08-31 Tadashi Matsushita, Amy Shapiro, Aby Abraham, Pantep Angchaisuksiri, Giancarlo Castaman, Katarina Cepo, Roseline d’Oiron, Melissa Frei-Jones, Ai-Sim Goh, Jesper Haaning, Sanja Hald Jacobsen, Johnny Mahlangu, Mary Mathias, Keiji Nogami, Josephine Skovgaard Rasmussen, Oleksandra Stasyshyn, Huyen Tran, Kateryna Vilchevska, Laura Villarreal Martinez, Jerzy Windyga, Chur Woo You, Nadezhda Zozulya, Bulent
Background Concizumab is an anti–tissue factor pathway inhibitor monoclonal antibody designed to achieve hemostasis in all hemophilia types, with subcutaneous administration. A previous trial of concizumab (explorer4) established proof of concept in patients with hemophilia A or B with inhibitors. Methods Download a PDF of the Research Summary. We conducted the explorer7 trial to assess the safety
-
Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction N. Engl. J. Med. (IF 158.5) Pub Date : 2023-08-27 Barbara E. Stähli, Ferdinando Varbella, Axel Linke, Bettina Schwarz, Stephan B. Felix, Moritz Seiffert, Rahel Kesterke, Peter Nordbeck, Bernhard Witzenbichler, Irene M. Lang, Mirjam Kessler, Christian Valina, Alban Dibra, Miklos Rohla, Marco Moccetti, Matteo Vercellino, Luise Gaede, Lorenz Bott-Flügel, Philipp Jakob, Julia Stehli, Alessandro Candreva, Christian Templin, Matthias Schindler, Manfred
Background In patients with ST-segment elevation myocardial infarction (STEMI) with multivessel coronary artery disease, the time at which complete revascularization of nonculprit lesions should be performed remains unknown. Methods We performed an international, open-label, randomized, noninferiority trial at 37 sites in Europe. Patients in a hemodynamically stable condition who had STEMI and multivessel
-
Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation N. Engl. J. Med. (IF 158.5) Pub Date : 2023-08-27 Vivek Y. Reddy, Edward P. Gerstenfeld, Andrea Natale, William Whang, Frank A. Cuoco, Chinmay Patel, Stavros E. Mountantonakis, Douglas N. Gibson, John D. Harding, Christopher R. Ellis, Kenneth A. Ellenbogen, David B. DeLurgio, Jose Osorio, Anitha B. Achyutha, Christopher W. Schneider, Andrew S. Mugglin, Elizabeth M. Albrecht, Kenneth M. Stein, John W. Lehmann, Moussa Mansour
Background Catheter-based pulmonary vein isolation is an effective treatment for paroxysmal atrial fibrillation. Pulsed field ablation, which delivers microsecond high-voltage electrical fields, may limit damage to tissues outside the myocardium. The efficacy and safety of pulsed field ablation as compared with conventional thermal ablation is not known. Methods In this randomized, single-blind, noninferiority
-
Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation N. Engl. J. Med. (IF 158.5) Pub Date : 2023-08-27 Christian Sohns, Henrik Fox, Nassir F. Marrouche, Harry J.G.M. Crijns, Angelika Costard-Jaeckle, Leonard Bergau, Gerhard Hindricks, Nikolaos Dagres, Samuel Sossalla, Rene Schramm, Thomas Fink, Mustapha El Hamriti, Maximilian Moersdorf, Vanessa Sciacca, Frank Konietschke, Volker Rudolph, Jan Gummert, Jan G.P. Tijssen, Philipp Sommer
Background The role of catheter ablation in patients with symptomatic atrial fibrillation and end-stage heart failure is unknown. Methods We conducted a single-center, open-label trial in Germany that involved patients with symptomatic atrial fibrillation and end-stage heart failure who were referred for heart transplantation evaluation. Patients were assigned to receive catheter ablation and guideline-directed